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Abstract
 
An analysis of expression of 137 lipoprotein genes on the course of murine infection revealed a
two-step molecular adaptation by 
 
Borrelia burgdorferi
 
, the Lyme disease spirochete. For the first
step, regardless whether the initial inocula of 
 
B. burgdorferi
 
 expressed either all (cultured spiro-
chetes) or less than 40 (host-adapted spirochetes) of the 137 lipoprotein genes, the spirochetes
were modulated to transcribe 116 of the genes within 10 d after being introduced to the mu-
rine host. This step of adaptation was induced by the microenvironment of the host tissue.
During the second step, which was forced by host immune selection pressure and occurred be-
tween 17 and 30 d after infection, 
 
B. burgdorferi
 
 down-regulated most of the lipoprotein genes
and expressed less than 40 of the 137 genes. This novel adaptation mechanism could be a criti-
cal step for 
 
B. burgdorferi
 
 to proceed to chronic infection, as the pathogen would be cleared at
the early stage of infection if the spirochetes failed to undergo this process.
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Introduction
 
Borrelia burgdorferi
 
, the Lyme disease spirochete, is main-
tained within a complex enzootic life cycle involving the
tick vector and the mammal. The spirochete adapts to
these diverse environments, in part, by selective gene ex-
pression. Environmental cues such as temperature (1, 2),
pH (2, 3), and nutrients or chemicals (4, 5) influence 
 
B.
burgdorferi
 
 gene expression in vitro, and the cultivation of
 
B. burgdorferi
 
 in dialysis membrane chambers implanted
into rat peritoneal cavities up-regulates several spirochetal
genes (6). The most dramatic modifications that occur as
 
B. burgdorferi
 
 migrates from ticks to the mammalian host
involve lipoprotein gene expression, such as the down-
regulation of outer surface protein A (OspA) and the up-
regulation of OspC (7, 8). The genome of 
 
B. burgdorferi
 
contains more than 150 open-reading frames that encode
putative lipoproteins, more than any other known bacte-
rium (9), and many are surface exposed or have direct con-
tact with the environment. These lipoproteins play major
roles in pathogenesis and immunity and are likely to be in-
volved in 
 
B. burgdorferi
 
 adaptation through the spirochete
life cycle.
 
Materials and Methods
 
Spirochete Isolate. B. burgdorferi
 
 B31 clone 5A11 (a gift from
Steven Norris, University of Texas, Houston, TX) was cultivated
in Barbour-Stoenner-Kelly H complete medium at 33
 
 
 
C (Sigma-
Aldrich). This isolate carries 21 linear and circular plasmids (10).
 
Mouse Inoculation with Cultured Spirochetes.
 
Both C3H/HeN (C3H)
and C3H/HeN-SCID (SCID) mice (4 to 6-wk-old; National In-
stitutes of Health, Bethesda, MD) were given one single intrader-
mal injection of 10
 
5
 
 spirochetes that were grown to stationary
 
phase. Mice were killed at intervals of 1 to 8 wk, starting at 10 d
after needle inoculation. Ears and skins were frozen immediately
in liquid nitrogen for RNA preparation.
 
Mouse Inoculation with Host-adapted Spirochetes.
 
Donor C3H mice
were infected by needle inoculation for 4 mo. Ear tissues were
cut into small pieces and implanted into the skin at the back of
naive C3H mice. Infected mice were killed at 11 to 40 d after
infection. Ears and skins were frozen in liquid nitrogen for RNA
preparation.
 
RNA Preparation from Cultured Spirochetes and Mouse Tissues.
 
Total RNA was purified from spirochetes grown to mid-logarith-
mic phase or mouse ears and skins using the RNeasy Mini Kit
(QIAGEN). To remove DNA contamination, RNA samples were
digested in solution with RNase-free DNase I (Life Technologies)
 
at 37
 
 
 
C for 3 h, and then loaded to the RNeasy Mini columns and
further treated with RNase-free DNase (QIAGEN) for an addi-
tional 30 min at room temperature. Digested samples were repuri-
fied and analyzed for potential DNA contamination by PCR.
 
cDNA Preparation.
 
RNA preparations were first annealed
with reverse oligonucleotide primers of 
 
flaB
 
 and all the 137 in-
vestigated lipoprotein genes in the presence of reverse transcrip-
tion (RT) buffer (Stratagene). All primer sequences are available
 
Address correspondence to Erol Fikrig, 608 Laboratory of Clinical Inves-
tigation, Section of Rheumatology, Department of Internal Medicine,
 
Yale University School of Medicine, 333 Cedar St., New Haven,
CT 06520-8031. Phone: 203-785-2453; Fax: 203-785-7053; E-mail:
erol.fikrig@yale.edu 
276
 
Molecular Adaptation of 
 
B. burgdorferi
 
by request. dNTPs and reverse transcriptase were added (Strat-
agene) and transcription was conducted at 42
 
 
 
C for 1 h. RNA–
cDNA hybrids were denatured at 95
 
 
 
C for 5 min and RNA
chains were hydrolyzed by digestion with 1.0 N NaOH at 65
 
 
 
C
for 15 min. After neutralization with 1.0 N HCl, cDNA was pu-
rified using the Quik PCR Product Purification Kit (QIAGEN).
 
PCR.
 
For each PCR reaction volume of 50 
 
 
 
l, cDNA that
was converted from 25 ng of total spirochetal RNA, 250 ng
RNA prepared from SCID mice with acute or chronic infection
or from C3H mice with acute infection, or 2,500 ng RNA from
C3H mice with chronic infection was applied. The amount of
cDNA that was used for each PCR reaction was determined by
twofold serial dilution PCR of the 
 
flaB
 
 gene.
 
Southern Blotting Confirmation of PCR Products by Microarray Hy-
bridization.
 
All PCR products were assessed by agarose gel elec-
trophoresis. Those that showed expected sizes were combined
and purified using the Quik PCR Product Purification Kit
(QIAGEN). Purified DNAs were incorporated with aminoallyl
dUTP by nick translation (Life Technologies), fluorescently la-
beled with the Alexa Fluor 647 kit (Molecular Probes, Inc.), and
allowed to hybridize to the lipoprotein DNA microarray (11).
The array was scanned with an Axon GenePix 4000A Array
Scanner (Axon Instruments, Inc.).
 
Sequencing of PCR Products.
 
PCR products of selective genes
were gel-purified using the QIAquick Gel Extraction Kit
(QIAGEN). Purified DNAs were sequenced.
 
Passive Immunization of SCID Mice with Anti-B. burgdorferi Anti-
sera. 
 
SCID mice were infected with cultured 
 
B. burgdorferi
 
 B31
and received three subcutaneous injections of 100-
 
 
 
l pooled
mouse antiserum or prebled (control) at 11, 13, and 15 d. Anti-
sera were collected from C3H mice that had been infected with
cultured spirochetes for 1 to 6 mo, while prebleed was drawn
from naive C3H mice. SCID mice were killed at 2 d after the last
passive immunization and ear tissues were frozen in liquid nitro-
gen for RNA preparation.
 
Results
 
Lipoprotein Gene Expression during In Vitro Cultivation.
 
To investigate the molecular adaptation of 
 
B. burgdorferi
 
 in
different environments, we first examined the expression of
137 putative lipoprotein genes during in vitro cultivation.
Total RNA was prepared from cultured spirochetes. To de-
termine if any DNA contamination was present, following
two DNase digestion treatments, the RNA preparation was
amplified by both PCR and RT-PCR using each primer
pairs of the first putative lipoprotein genes carried by all of
the 20 lipoprotein-carrying genetic elements: one chromo-
some and 19 plasmids (9). Both RT-PCR and PCR prod-
ucts were assessed by agarose gel electrophoresis. The results
obtained from plasmids J (lp38), K (lp36), L (cp32–8), M
(cp32–6), N (cp32–9), O (cp32–7), P (cp32–1), Q (lp56),
R (cp32–4), and S (cp32–3) were selectively presented in
Fig. 1. The RT-PCR products only showed amplicons
with expected sizes, indicating that DNA contamination
was not detectable. Then, the 117 remaining lipoprotein
genes were individually amplified by RT-PCR, and the
 
flaB
 
 gene was used as a control and also amplified. Resultant
products were assessed by agarose gel electrophoresis and all
showed the expected sizes. To more definitively examine
the gene expression, 
 
flaB
 
 and all 137 lipoprotein PCR
products were combined, purified, fluorescently labeled,
and allowed to hybridize to a lipoprotein DNA microarray.
In vitro cultivated spirochetes expressed virtually all of these
137 (putative) lipoprotein genes (Fig. 2 A). These data were
confirmed in a separate experiment.
 
Lipoprotein Gene Expression on the Course of Infection in Im-
munodeficient Mice.
 
We next examined lipoprotein gene
expression in infected SCID mice. 10 animals were in-
fected with cultured 
 
B. burgdorferi
 
 and killed at 10, 17, 24,
31, 45, 60, 75, 100, 130, and 180 d. Total RNA was pre-
pared and amplified by RT-PCR. PCR products were an-
alyzed by agarose gel electrophoresis and microarray hy-
bridization. 
 
B. burgdorferi
 
 quickly down-regulated 21 of the
lipoprotein genes within 10 d after introduction into the
immunodeficient host (Fig. 2 B). These down-regulated
genes included 
 
bb0098
 
, 
 
bb0424
 
, 
 
bb0464
 
, 
 
bb0475
 
, 
 
bb0664
 
,
 
bb0740
 
, 
 
bb0840
 
, 
 
bba15
 
, 
 
bba62
 
, 
 
bbb08
 
, 
 
bbe06
 
, 
 
bbe08
 
, 
 
bbe28
 
,
 
bbg25
 
, 
 
bbh32
 
, 
 
bbi28
 
, 
 
bbi32
 
, 
 
bbk04
 
,
 
 bbo40
 
,
 
 bbq05
 
, and
 
 bbr42
 
.
The 116 remaining genes were persistently transcribed
throughout the entire 6-mo study period, as their mRNA
transcripts were detectable by RT-PCR in all of the nine
mice that were killed at 17 to 180 d after infection (data
not shown). Neither 
 
bbo40
 
 (
 
erpM
 
) or 
 
bbr42
 
 (
 
erpY
 
) ampli-
cons were revealed by agarose gel electrophoresis but these
genes’ DNA spots were reactive on the microarray (Fig. 2
B), probably due to the cross-hybridization of other 
 
erp
 
gene PCR products with these genes’ DNA fragments on
the microarray. The sequences of the 
 
erp
 
 family share high
percentages of identity (9). Although the 
 
ospA
 
 (
 
bba15
 
)
mRNA transcript was not detected, surprisingly, 
 
ospB
 
(
 
bba16
 
) was continuously expressed throughout infection.
The 
 
ospB
 
 PCR product was sequenced to confirm that this
gene was transcribed (data not shown).
 
Lipoprotein Gene Expression on the Course of Infection in Im-
munocompetent Mice.
 
As immune selection pressure could
influence the gene expression of surface-exposed, Ab-tar-
geted lipoproteins (12), we investigated 
 
B. burgdorferi
 
 lipo-
protein expression under immune selection pressure. RNA
Figure 1. Amplification of selected B.
burgdorferi lipoprotein genes that are ex-
pressed on the plasmids. Total RNA was
prepared from cultured B. burgdorferi and
analyzed by both PCR (–) and RT-PCR
( ). PCR products were separated by
ethidium bromide–incorporated agarose
gel, and the lack of a product in the (–) col-
umn demonstrated that DNA was not
present in the RNA preparation. 
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was prepared from 10 immunocompetent C3H mice that
were infected with cultured spirochetes for 10 to 180 d,
and analyzed by RT-PCR and microarray hybridization.
 
B. burgdorferi
 
 expressed a similar set of lipoprotein genes as
detected in infected SCID mice (Fig. 2 B) when the mouse
was examined at 10 d after infection. At 17 d, however,
most of the 116 lipoprotein genes that were expressed at 10 d
were down-regulated by immune selection pressure elic-
ited by infection (data not shown). Less than 40 of the lipo-
protein genes were continuously expressed when infected
C3H mice were examined at 24, 31, 45, 60, 73, 100, 130,
and 180 d after infection (Fig. 2 C). These results demon-
strated that early and chronic infections constitute two re-
markably different environments for 
 
B. burgdorferi
 
 adapta-
tion and the development of immune selection pressure in
the host significantly impacts lipoprotein gene expression.
 
Molecular Adaptation of B. burgdorferi during Murine Infec-
tion. 
 
To further investigate the influence of immune se-
lection pressure on 
 
B. burgdorferi
 
 adaptation, spirochetes that
had been adapted under immune selection pressure were
used for inoculation. Donor mice were first infected with
cultured 
 
B. burgdorferi
 
. 4 mo later, after the spirochetes had
adapted and expressed less than 40 lipoprotein genes (Fig.
3), ear tissues were taken from the donors and transplanted
into nine naive immunocompetent mice. 
 
B. burgdorferi
 
 re-
expressed all of the 83 down-regulated lipoprotein genes
when five recipient mice were examined at 11 to 22 d after
tissue transplantation (Fig. 3). This reexpression persisted
for 
 
 
 
2 wk. 
 
B. burgdorferi
 
 redown-regulated all of these re-
expressed genes within 5 wk after the initial transplantation
(Fig. 3), as their mRNA transcripts became undetectable
when four recipient mice were examined at 33 d or later.
These results further confirmed the influence of immune
pressure on 
 
B. burgdorferi
 
 adaptation.
It took 5 wk for host-adapted 
 
B. burgdorferi
 
 to finish the
adaptation to the immune selection pressure but only 3.5
wk for the cultured spirochetes to complete the same pro-
cess (Figs. 2 C and 3). The temporal difference may be due
to the fact that cultured 
 
B. burgdorferi
 
 expressed all of the li-
poproteins while the host-adapted spirochetes had down-
regulated all of the adaptable genes and thus must reex-
presses to trigger the immune response. In addition, the
spirochete inoculation dose may also be a factor as the tis-
sue implantation introduced fewer organisms than the nee-
dle inoculation.
 
Dominant Role of the Humoral Response in B. burgdorferi
Adaptation. B. burgdorferi
 
 is primarily an extracellular patho-
gen and the humoral response has been shown to play a crit-
ical role in immunity and disease regression. To carefully ex-
amine the role of Abs in 
 
B. burgdorferi
 
 molecular adaptation,
four infected SCID mice were passively immunized with
antisera from infected immunocompetent mice and two re-
ceived normal mouse sera as controls. Almost all the lipopro-
tein genes that were down-regulated by immune selection
pressure in immunocompetent mice were no longer ex-
pressed in the four passively immunized SCID mice but ex-
pressed in the two controls (data not shown). Several of the
genes, however, were not down-regulated in the passive
Figure 2. Lipoprotein gene expression of B. burgdorferi in in vitro culti-
vation (A), infected SCID mice (B), and C3H mice (C). flaB and 137 li-
poprotein gene fragments were amplified from B. burgdorferi B31 DNA
and printed in triplicate on the microarray. The location of each DNA
fragment was listed on Fig. 3, and locations I4, I8, R3, R4, R7, and R8
were blank. RNA was prepared from cultured spirochetes (A), the ear
tissues of SCID mice that had been infected with cultured B. burgdorferi
for 10 d (B), or the ear tissues of C3H mice that had been infected
with cultured B. burgdorferi for 24 d (C), and amplified by RT-PCR.
Purified PCR products were fluorescently labeled and hybridized to
the microarray. 
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transfer studies including 
 
bb0122
 
,  bb0155,  bba34,  bbe31,
bb01, bbh18, and bbi29. The fact that passive immunization
could not provide as high a level of Ab as those elicited by
infection might be the reason why some of the 83 down-
regulated genes in infected immunocompetent mice were
still expressed at a detectable level in the passively immu-
nized SCID mice. Alternatively, the host cellular immune
response may also play a role in B. burgdorferi adaptation.
Discussion
B. burgdorferi expressed all of the 137 lipoprotein genes we
investigated during in vitro cultivation (Fig. 2 A). Once the
spirochete was introduced into the mammalian host, how-
ever, 21 of the lipoprotein genes were quickly down-regu-
lated (Fig. 2 B). As expected, one of the down-regulated
genes was ospA. B. burgdorferi does not prominently express
ospA during mammalian infection but overexpresses this li-
poprotein within the tick vector (7, 8) to facilitate the ad-
herence of B. burgdorferi to the tick midgut (13). When
OspA is expressed in the reservoir host, it would elicit
strong immune responses including the development of
OspA Ab. As a consequence, acquisition of the spirochetes
from mammals by larval ticks would be impaired or even
blocked (14). Therefore, B. burgdorferi does not generally ex-
press ospA during infection of its natural mammalian host in
order to maintain the enzootic cycle. OspA Ab may some-
times be found in patients with Lyme disease (15); however,
humans are an aberrant host and not important for spiro-
chete persistence. Most of the 20 remaining down-regulated
lipoprotein genes are hypothetical. It remains to be ad-
dressed if they are, like ospA, also tick-specifically expressed.
A group of  80 lipoprotein genes were persistently ex-
pressed during murine infection when no immune selec-
Figure 3. Molecular adaptation of B. burgdorferi
in the murine host. C3H mice that had been in-
fected with cultured B. burgdorferi for 4 mo were
used as donors. Naive C3H mice received ear tissue
implants and were killed 11, 22, and 33 d later.
RNA was prepared from ears and analyzed for the
expression of the 137 putative lipoprotein genes
and flaB by RT-PCR and microarray hybridiza-
tion. “Location,” location of each gene’s DNA
fragment on the microarray; “ ,” expressed; “–,”
not expressed.279 Liang et al. Brief Definitive Report
tion pressure was present. ospC (bbb19) is the best known
member of this group. OspC has been identified as an Ab-
targeted, surface-exposed Ag during murine infection (12).
To avoid immune clearance by OspC Ab during mamma-
lian infection, B. burgdorferi shuts down ospC (12). Although
the other members of this group also appeared to be down-
regulated by immune selection pressure elicited during in-
fection, it remains to be addressed whether they are, like
OspC, surface-exposed, Ab-targeted Ag. Some of them
might be neither surface-exposed nor Ab-targeted but
could be codown-regulated with other Ab-targeted Ag(s).
The third group of lipoproteins were expressed through-
out mammalian infection. Some of them were significantly
down-regulated by immune selection pressure but their ex-
pression was detectable. They may be critical for the survival
of B. burgdorferi in the mammalian host. As expected, VlsE
(BBF32) was continuously expressed since it is able to un-
dergo antigenic variation during murine infection (16).
Three of the four-member Bmp family (17), BmpB, BmpC,
and BmpD (BB0382, BB0384 and BB0385), but not BmpA
(BB0383), were also persistently found. Although the func-
tions of these lipoproteins are unknown, they are homolo-
gous to TmpC, a putative outer or cytoplasmic membrane
lipoprotein of Treponema pallidum, the spirochetal agent of
syphilis (18), indicating the importance of these lipoproteins
in the spirochetes’ pathogenesis. The best known members
of this group are decorin-binding proteins A and B (DbpA
and DbpB; BBA24 and BBA25; reference 19) and fibronec-
tin-binding protein (BBK32; reference 20). These three li-
poproteins have been shown in vitro to be surface exposed
and be able to bind extracellular matrices (19, 20). Recent
evidence suggests that Dbps interact with their ligand and
enhance the infectivity of B. burgdorferi during murine infec-
tion (21). It remains to be addressed if host decorin or fi-
bronectin can coat B. burgdorferi via the Dbps and fibronec-
tin-binding protein, and thus protect the pathogen from
attack by specific Ab. ErpK (BBM38), ErpA (BBP38), and
ErpX (BBQ47) were expressed in chronically infected im-
munocompetent mice, albeit some of them were transcribed
at a very low level or even undetectable in some cases. In-
terestingly, like BBA24, BBA25, and BBK32, the Erp lipo-
proteins also are able to bind a host component, comple-
ment inhibitor factor H (22).
Some of our findings strikingly differ from those that
have been obtained with cultured B. burgdorferi. For in-
stance, ospA and ospB are transcribed as a single mRNA
unit in cultured B. burgdorferi (23). Our study indicated that
B. burgdorferi expressed ospB but not ospA throughout mu-
rine infection. Hübner and colleagues have reported an
RpoN-RpoS regulatory pathway that controls the expres-
sion of both dbpA and ospC (24). Our study, however,
clearly showed that whereas B. burgdorferi expressed both
genes in SCID mice, immune selection pressure shut down
ospC but not dbpA. The differential expression of these two
lipoproteins has already been reported in the tick vector
(25). B. burgdorferi has coevolved with the mammalian (im-
munocompetent) host and tick vector for a long period of
time. The in vitro artificial conditions probably constitute
an aberrant environment where B. burgdorferi changes pro-
tein expression profiles and can more easily lose plasmids,
infectivity, and pathogenicity (26).
There are no existing mechanisms that can be used to ex-
plain how immune selection pressure down-regulates spe-
cific genes. A previous study indicates that B. burgdorferi is
able to generate multiple phenotypes during murine infec-
tion (12). Different phenotypes may express unique sets of
lipoproteins and these phenotypes can interconvert. B. burg-
dorferi infection elicits the immune responses including those
to surface-exposed lipoproteins once they are expressed.
The specific Abs selectively eliminate the phenotypes that
express these Ab-targeted Ags. The Ab-targeted phenotypes
are continuously generated and then eliminated during in-
fection. Some of the lipoprotein genes might exhibit this
“down-regulation phenomenon.” Coexistence of multiple
phenotypes of B. burgdorferi has already been observed in the
tick vector (27) as well as in vitro cultivation (28). This se-
lection hypothesis can explain some but not all of the obser-
vations that have been obtained to date. For instance, if Ab-
targeted phenotypes were continuously generated, specific
lipoprotein mRNAs could be positive by sensitive RT-
PCR even though these newly “borne” spirochetes were
immediately eliminated. Moreover, if Ab-targeted pheno-
types were continuously generated, newly synthesized lipo-
proteins would constantly prime the immune system. As a
consequence, the specific Ab response to Ab-targeted lipo-
proteins should be maintained. However, the analysis of the
Ab response to selected lipoproteins, such as OspC, in in-
fected white-footed mice and human patients with Lyme
disease does not support this view. The OspC Ab titer sub-
stantially wanes while infection continues in white-footed
mice (29). In human patients, the OspC Ab titer may fall
below a detectable level as the infection persists, and then
reappear months later (30). If OspC-expressing spirochetes
were continuously generated, the anti-OspC response
should persist throughout the infection. Therefore, at least,
some of the lipoprotein genes could be turned off by spe-
cific Ab by mechanisms that have not been known yet.
Our study has clearly demonstrated a two-step process of
molecular adaptation by B. burgdorferi during early murine
infection. The first-step adaptation is induced by the mi-
croenvironment of the host tissues. Regardless whether
cultured B. burgdorferi, which expressed all of the 137 lipo-
protein genes, or host-adapted organisms, which expressed
less than 40 of them, were used for inoculation, the spiro-
chetes were modulated to transcribe the same set of 116 li-
poprotein genes within 10 d after infection. During the
second step of adaptation, immune selection pressure
forced spirochetes to down-regulate more than 80 of these
116 genes. This adaptation is a fundamental for B. burgdor-
feri to establish chronic infection, as the pathogen would be
cleared by the host immune system at the very early stage
of infection if the spirochete failed to undergo the process.
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